2004年
- Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H, Utsunomiya T, Barnard GF, Inoue H, Mori M.
Clin Cancer Res. 2004 Dec 15;10(24):8243-9. - Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.
Utsunomiya T, Inoue H, Tanaka F, Yamaguchi H, Ohta M, Okamoto M, Mimori K, Mori M.
Ann Surg Oncol. 2004 Oct;11(10):934-40. - N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.
Yoshinaga K, Inoue H, Utsunomiya T, Sonoda H, Masuda T, Mimori K, Tanaka Y, Mori M.
Clin Cancer Res. 2004 Sep 1;10(17):5702-7. - A gene-expression signature can quantify the degree of hepatic fibrosis in the rat.
Utsunomiya T, Okamoto M, Hashimoto M, Yoshinaga K, Shiraishi T, Tanaka F, Mimori K, Inoue H, Watanabe G, Barnard GF, Mori M.
J Hepatol. 2004 Sep;41(3):399-406. - Analysis of gastric cancer with cDNA microarray.
Haraguchi N, Inoue H, Mimori K, Tanaka F, Utsunomiya T, Yoshikawa K, Mori M.
Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S21-4. - Prediction of 5′-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes.
Mimori K, Ueo H, Kuroki T, Shiraishi T, Creer S, Taylor S, Ishii H, Mori M.
Oncol Rep. 2004 Jul;12(1):19-23. - Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Yamashita K, Tanaka Y, Mimori K, Inoue H, Mori M.
Int J Cancer. 2004 Jun 10;110(2):201-7. - Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
Ishii H, Mimori K, Vecchione A, Sutheesophon K, Fujiwara T, Mori M, Furukawa Y.
Biochem Biophys Res Commun. 2004 Apr 16;316(4):1088-93.